Samsung Biologics Clears Tender Offer Threshold for PolyPeptide Group
A view of the Samsung Biologics building. Photo courtesy of Samsung Biologics Samsung Biologics (207940.KS) has cleared the…
#EuropeSays #Korea #KR #SamsungBiologics #obesitydrugs #PeptideCDMO #pharmaceuticalM&A #PolyPeptideGroup #Samsung #SamsungPeptide #tenderoffer
https://www.europesays.com/korea/186570/